Dr. Michael J. Borodkin, MD

Dr. Borodkin practices at New York Eye and Ear Infirmary of Mount Sinai in New York, New York, part of Mount Sinai Health System.

Dr. Borodkin's NPI, 1801903349, was assigned on August 23, 2006. Dr. Borodkin graduated from Yale School of Medicine in 1991. Dr. Borodkin holds New York license 191081.

Dr. Borodkin's primary practice is New York Eye and Ear Infirmary of Mount Sinai, at 230 Second Ave, New York, NY 10003 in New York County. The practice phone is (212) 979-4000. Dr. Borodkin also practices at New York Eye & Ear Infirmary, 310 E 14th St, New York, NY 10003.

Dr. Borodkin's primary practice is New York Eye and Ear Infirmary of Mount Sinai in New York, New York, part of Mount Sinai Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borodkin practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Borodkin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Borodkin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Borodkin's licenses on file in 2 states: New York and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Borodkin treats.

CMS data shows 1,794 Medicare services from Dr. Borodkin across 13 procedure codes in 2024, for 728 Medicare patients. Medicare paid $144,263 for them.

CMS counts 728 Medicare patients who saw Dr. Borodkin in 2024. The largest group is 75 to 84, with 347 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Borodkin's median patient age at 63, with 57% women.

In 2024, Dr. Borodkin wrote 459 Medicare Part D claims for 152 patients. 52% of them were for generic drugs. CMS names the drug for 336 of them, across 12 drugs with 11 or more claims each, at $55,045 in total drug cost. In 2023, CMS named 449 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Borodkin for performance year 2024, reported individually. Dr. Borodkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of cataract surgery by Dr. Borodkin, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Borodkin.

CMS Open Payments shows 44 general payments to Dr. Borodkin from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sun Pharmaceutical Industries Inc. paid the most, $348.

Dmand AI lists 1 award for Dr. Borodkin.

Dr. Borodkin graduated from Yale School of Medicine in 1991. Dr. Borodkin is a member of AAO.

Dr. Borodkin is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.